Evidence map›Paper›PMID 33994434›Full record

ArticleInternal medicine (Tokyo, Japan)2021

Streptococcal Toxic Shock Syndrome Induced by Group A Streptococcus with the emm28 Genotype That Developed after a Uterine Cancer Test.

Yusuke Yamaba, Osamu Takakuwa, Chiaki Ida, Manami Saito, Daisuke Kawae, Misuzu Yoshihara, Eiji Kunii, Kenro Imaeda, Ichiro Tatsuno, Tadao Hasegawa and 1 more

Abstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yusuke YamabaDepartment of Respiratory Medicine, Nagoya City University West Medical Center, Japan.
Osamu TakakuwaDepartment of Respiratory Medicine, Nagoya City University West Medical Center, Japan.
Chiaki IdaNagoya City University Medical School, Japan.
Manami SaitoDepartment of Respiratory Medicine, Nagoya City University West Medical Center, Japan.
Daisuke KawaeDepartment of Respiratory Medicine, Nagoya City University West Medical Center, Japan.
Misuzu YoshiharaDepartment of Respiratory Medicine, Nagoya City University West Medical Center, Japan.
Eiji KuniiDepartment of Respiratory Medicine, Nagoya City University West Medical Center, Japan.
Kenro ImaedaDepartment of Endocrinology and Diabetes, Nagoya City University West Medical Center, Japan.
Ichiro TatsunoDepartment of Bacteriology, Nagoya City University Graduate School of Medical Science, Japan.
Tadao HasegawaDepartment of Bacteriology, Nagoya City University Graduate School of Medical Science, Japan.
Kenji AkitaDepartment of Respiratory Medicine, Nagoya City University West Medical Center, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 69-year-old woman without pre-existing disease visited our hospital due to general malaise, diarrhea, and arthralgia 3 days after a uterine cancer test. We diagnosed her with sepsis of unknown focus and started treatment immediately, but she died 20 hours after the first visit due to multi-organ failure and septic shock. Later, group A streptococcus was detected from the blood culture, and streptococcal toxic shock syndrome (STSS) was diagnosed. The strain had the emm28 genotype and a mutation in csrR with increased NADase activity. These virulence factors were considered to be related to STSS development in this patient.

Indexed as

Shock, SepticStreptococcal InfectionsUterine NeoplasmsAgedFemaleGenotypeHumansStreptococcus pyogenescsrRemmNADaseSTSS

Identifiers

PMID33994434
PMCPMC8627819

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.